NEW ORLEANS, LA—Data presented at ACC.11, the American College of Cardiology’s 60 th Annual Scientific Session, demonstrated that combination ezetimibe/simvastatin + extended-release niacin (E/S+N) is ...

SAN DIEGO — High-risk patients with ACS assigned simvastatin plus ezetimibe had fewer total and recurrent events compared with those assigned simvastatin alone, according to new data from the ...

The study was a randomized, placebo-controlled comparison of the effects of daily treatment with fenofibrate 160 mg, ezetimibe-simvastatin 10/20 mg, ezetimibe-simvastatin 10/20 mg plus fenofibrate 160 ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Treatment with combination ezetimibe and simvastatin plus extended-release niacin may aid patients ...

LONDON, July 21 /PRNewswire/ -- The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study has investigated the effects of intensive cholesterol lowering with the combination of simvastatin (40 mg ...

Two previous trials failed to demonstrate the effectiveness of statins for preventing adverse cardiovascular events in patients on dialysis (JW Cardiol Aug 19 2005 and Mar 30 2009). In SHARP, a ...

On top of simvastatin therapy, the cholesterol-lowering agent ezetimibe may improve cardiovascular outcomes, according to data from the IMPROVE-IT study published online June 3, 2015, ahead of print ...

The first United Kingdom Heart and Renal Protection study established simvastatin as an effective, well-tolerated cholesterol-lowering treatment for patients with chronic kidney disease (CKD). Now, ...

HealthDay News— For patients with hypercholesterolemia, simvastatin is superior to ezetimibe for producing lymphocyte-suppression and systemic anti-inflammatory and endothelial protective effects, ...

LONDON, September 6 /PRNewswire/ -- AstraZeneca today announced enrolment of the first patient in the new GRAVITY study (Gauging the lipid effects of RosuvAstatin plus ezetimibe Versus sImvastatin ...